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Introduction
Head and neck cancers (HNCs) are the most dangerous types of cancers. Because of proximity of tumor site to the neck lymph nodes, development of cancer to other parts of body is at a high 
risk, and so, they are much better to be treated quickly. HNC is a general 
term which involves malignant tumors of breathing and superior gastro-
intestinal regions including the oral cavity, nasopharynx, oropharynx, 
hypopharynx, Larynx and salivary glands [1]. It is estimated that 644 
thousand new cases of HNCs are reported annually worldwide among 
which two-thirds of cases occur in developing countries. The population 
Original
ABSTRACT
Background: Head and neck cancers are currently the most common types of 
cancers. 3D-conformal radiation therapy is the most common dose delivery tech-
nique for head and neck cancers. Eye Lens is a radio sensitive structure and cataract 
formation as a visual disorder associated with exposure to ionizing radiation which is 
documented.  
Objective: Determining the radiation dose to eye lens during head and neck radi-
ography and estimating the probability of cataract induction are essential.
Material and Methods: This experimental study was performed on 14 pa-
tients with head and neck cancers through experimental study analysis. The maxi-
mum opacity of the eyes lens were measured by pentacamTM before radiation therapy. 
CT data of patients were transmitted to Isogray treatment planning Software, and 
dose calculations for each patient was performed. At the end of radiation treatment, 3 
and 6 months after radiotherapy, the eye lens opacity of the patients was assessed. 
Results: Overall, 28 lenses were studied. Statistical one sample K- S test proved 
normality of obtained data. Using repeated measures test, the relation before and 3 
months after radiotherapy, as well as the relationship before and 6 months after radio-
therapy proved a significant relationship. 
Conclusion: The opacity caused by radiation in eyes is a non-statistical and lin-
ear-quadratic response curve with no threshold. This opacity can also appear within 3 
months after completion of radiation therapy. 
Citation: Arefpour AM, Bahrami M, Haghparast A, Khoshgard K, Aryaei Tabar H, Farshchian N. Evaluating Dose-response of Cataract Induc-
tion in Radiotherapy of Head and Neck Cancers Patients. J Biomed Phys Eng. 2021;11(1):9-16. doi: 10.31661/jbpe.v0i0.834. 
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at risk of these types of cancers are people with 
long-term history of smoking and drinking. 
However, the statistical rate, age and gender 
of patients in several studies in recent decades 
have been changing. Such as the fact that this 
type of cancer is more common in men, but 
its incidence in women has increased [2]. Ra-
diation therapy by high energy X-rays or other 
ionizing particles for the destruction of can-
cer cells are used. Radiation therapy is usu-
ally given a diet containing a certain number 
of doses of radiation during certain meetings 
and certain time. Radiation therapy is mainly 
used for HNC treatment, especially after sur-
gery or for the cases in which tomural cells 
cannot be removed by surgery [3]. Eye lens is 
a radio sensitive structure, and cataracts as a 
side effect associated with exposure to ioniz-
ing radiation has been documented [4]. Cata-
racts also is the most common cause of blind-
ness worldwide [5]. The major risk factors 
for developing cataracts include: congenital 
cataracts due to age, diabetes, corticosteroids 
use, nicotine and alcohol usage, exposure to 
non-ionizing radiation and ionizing radiation 
[6, 7]. Based on clinical appearance, cataracts 
can be defined as three main types: central 
cataracts (opacities are mainly located at the 
center of lens), cortical cataracts (opacities 
are mainly peripheral and central parts gradu-
ally drawn), and subcapsular cataract (which 
forms in the back of lens) [7, 8]. Cataract is 
caused by radiation because of irradiation to 
germinative area. When dividing cells of this 
(germinative) are damaged due to radiation 
effects, abnormal lens fibers are not removed 
and disposed, therefore, cataract formation 
will begin. The incubation period and the se-
verity of radiation-induced cataracts depend 
on radiation dose, dose rate and fractionation. 
It has been reported that the incubation period 
for the development of radiation-induced cata-
racts is inversely related to the dose of radia-
tion [9].
The tolerance dose of 2 Gy at chronic and 
4 Gy at acute exposures for radiation-induced 
cataract had been reported by International 
Committee of Radiobiological Protection 
(ICRP) publication No.103 in 2007 [10, 11]. In 
2006 Nakashima et al., analyzed this threshold 
dose for cataracts in the atomic-bomb survi-
vors; the number of 873 persons aged less than 
13 years were considered, and examinations 
were performed at the age of 55. In this study, 
a threshold equivalent dose of 0.6Sv was re-
ported [12]. In 2011, ICRP at its publication 
No.118, reported the lowest threshold dose of 
0.5 Gy for the lens of the eyes to create the 
opacity [13].
The aim of this study was determining the 
dose-response curve of radiation induced cata-
racts during a 6 months the follow-up in pa-
tients with head and neck cancers. 
Material and Methods
In this experimental study, 14 patients with 
head and neck cancers were considered. Inclu-
sion criteria consisted of a primary malignan-
cy in head and neck region needing to receive 
radiation therapy as primary or complemen-
tary treatment. All patients were enrolled with 
personal satisfaction.
Both eyes of the patients were examined 
using Pentacam (Oculus-Germany) to mea-
sure the maximum opacity of the lens of the 
eye at a point; (measuring the average opac-
ity caused by radiation, over a period of more 
than 6 months after completion of radiation 
therapy can be significant, so the maximum 
opacity in the lens of the eye was measured 
at one point). CT-scan (Toshiba, Japan) for all 
patients was done before treatment planning 
with 120 KVp, 200 mA and 4- mm slice thick-
ness. Patients were immobilized with ther-
moplastic masks during imaging. CT data of 
each patient was transferred to treatment plan-
ning software (Isogray, DosiSoft, France), and 
treatment planning in head and neck region 
was performed on tumor volume. The eye 
lenses were identified and planned as healthy 
organs at risk. Radiation therapy was done as 
three dimensional conformal radiation therapy 
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(3D-CRT) method, and irradiations to tumor 
site were done by technique using a linear ac-
celerator (ELEKTA, England).
Results
In this study, 14 patients with mean age of 
55.64 ± 11 years (range; 39 – 72 years) were 
studied. Of the patients, 6 patients (42.86 %) 
parotid cancer, 5 patients (35.7 %) Larynge-
al cancer and 3 patients (21.43 %) had been 
suffering from a brain tumor. Also, 5 patients 
(35.7%) had smoking habit, and 10 patients 
(71.43 %) had concurrent chemotherapy. All 
patients had no history of any previous eye 
surgery or diabetes (Table 1).
The data of prescribed dose and dose re-
ceived by eyes lenses are tabulated in Table 2. 
The absorbed dose of left and right eye lenses 
were in the range of 1-2000 cGy and 1-2293 
cGy, respectively.
The maximum opacity of the eye lenses 
of the patients before, after 3 months and 6 
months after radiotherapy are listed in Table 3. 
Since left and right eye lenses are physiologi-
cally independent and opacity in one eye will 
have no effect on the other eye, left and right 
eye lenses (28 ones) were considered sepa-
rately. The average ± standard deviation of 
maximum opacity induced in the lenses of the 
eyes before, 3 months after radiotherapy and 6 
months after radiotherapy are shown in Table 
4. One sample K-S test showed the distribu-
tion of the obtained data was normal. In addi-
tion, the repeated measures test used to check 
the significant relationship before and after 
radiation therapy measurements. The unifor-
mity of covariance was tested with Mauchly 
test (SPSS, V. 20); the significance level of 
the test was obtained less than 0.05 (p=0). P-
Value is offered in Sphericity rows-Sphericity 
Assumed (p=0), Greenhouse-Geisser (p=0), 
Huynh-Feldt (p=0) and lower-bound (p=0) the 
analysis of variance was less than 0.05. Statis-
tical analysis of repeated measurements dem-
onstrated a statistically and clinically signifi-
cant relationship between the opacity before 
and 3 months after radiation therapy (p=0), 
as well as before and 6 months after radiation 
therapy (p=0). Then, Curve fitting for the se-





Duration of smoking 
(years)
Tumor 
Bed Chemotherapy  
History of 
eye Surgery Diabetic
1 M 39 20 parotid Yes No No
2 F 40 0 parotid Yes No No
3 F 63 0 parotid No No No
4 M 72 0 Laryngeal Yes No No
5 M 50 20 Laryngeal Yes No No
6 M 65 50 Laryngeal No No No
7 M 44 22 Laryngeal Yes No No
8 M 63 0 brain No No No
9 M 69 0 Laryngeal Yes No No
10 M 51 0 brain Yes No No
11 F 58 0 parotid No No No
12 M 60 40 parotid Yes No No
13 M 42 0 brain Yes No No
14 F 61 0 parotid Yes No No
Table 1: Demographic information of the patients.
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Left eye lens 
dose (cGy)
Right eye lens 
dose (cGy)
1 6 4600 23 102 102
2 6 6600 33 1042 1787
3 6 2000 22 133 90
4 6 7000 35 70 60
5 6 4600 23 1 1
6 6 7000 35 120 1
7 6 4600 23 48 51
8 6 4600 23 228 227
9 6 4600 23 54 57
10 6 5000 25 2000 2293
11 6 4000 21 330.6 368.1
12 6 4600 23 700 1600
13 6 5400 30 1500 1260
14 6 2000 10 230 600
Table 2: Dosimetric data of the patients.
Max opacity before radia-
tion therapy (RT) (%)
Max opacity at 3 months after 
radiation therapy (RT) (%)
Maximum opacity 6 
months after RT (%)
Patient No. Left lens Right lens Left lens Right lens Left lens Right lens
1 58 65.1 59.1 67.1 59.6 67.9
2 33.3 52.9 39.2 65.2 41.8 68.1
3 12.9 22 13.7 22.7 14.9 24.9
4 51 61.2 52.6 63 53.9 63.6
5 25.5 29 27 30.2 28.7 30.8
6 52.2 47.5 53.6 48.6 54.9 49
7 77.6 78 78.5 79.2 79.2 79.6
8 54.5 52.2 55.8 53.3 57.3 54.1
9 38.4 34.9 39.9 35.9 40.5 36.2
10 34.5 38.8 45.7 51.9 50.3 55.3
11 38 30.6 38.4 32.3 39.2 32.8
12 30.2 34.5 32.7 46.8 34.8 49.7
13 27.8 36.1 33.3 42.2 35.7 44.8
14 27.5 28.6 28.9 30.8 30.4 31.8
Table 3: Maximum opacity of the eyes lens of the patients before, 3 months and 6 months after 
radiation therapy (RT).
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Y= 0.131X1.475 + 1.23                    Equation (1)
Y= 0.2066X1.397 + 1.862                  Equation (2)
Discussion
Radiation dosimetry in radiation therapy 
(RT) has a great importance; successful RT re-
quires precise radiation dose delivery to can-
Mean ± SD
Before radiation therapy 3 months after radiation therapy 6 months after radiation therapy
41.89 ± 16.3 45.27 ± 16.35 46.78 ± 16.24
Table 4: Mean and standard deviation of opacity at a point of the lenses.
Figure 1: Changes in average opacity of the patients’ eye lens from before radiation therapy to 
6 months after radiation therapy
Figure 2: Maximum opacity of the eye lens in 3 months after radiation therapy.
points were done and then shown in Figures 1, 
2, 3 and Table 4. 
Equations 1 and 2, respectively correspond 
to Figures 2 and 3 were determined using 
MATLAB software (version 2016) in which 
x=Eye lens dose (Gy), Y=maximum opacity 
(%). 
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cer tissue volume, so the lowest dose received 
by surrounding healthy tissue. As a general 
rule, one must try healthy tissues to get mini-
mal dose while the lethal and uniform radia-
tion doses are delivered to tomural tissue. 
Over the years, radiologists have known the 
lens might be damaged by radiation. Study 
of patients treated with X- and gamma rays 
showed the formation of cataract caused by 
radiation exposure in human. Cataract caused 
by radiation in most cases is naturally different 
from the lesions caused by natural factors or 
other complex types of cataract.
Most cases were subcapsular and central 
cataracts. However, other studies have shown 
the opacity caused by radiation ordinarily in-
cluding: subcapsular, cortical and central cata-
racts. Richard et al., [14] investigated the cata-
ract caused by microwave radiation, ionizing 
radiation and concluded that cataract induced 
by ionizing radiation (e.g., X- and gamma 
rays) are often in the form of a cataract sub-
capsular. In 1999, Hall et al., [15] investigated 
the correlation between dose and induction of 
cataract lens in children less than 18 months 
with skin hemangioma treated with ionizing 
radiation. A number of 484 patients exposed 
to radiation (with mean dose of lenses of 0.4 
Gy and rage of 0 to 8.4 Gy) were considered, 
and inductions of lens opacity were studied all 
at the age of 36-45 years for all patients. As a 
result, 357 of patients were affected by sub-
capsular and cortical cataract [15]. Minamoto 
et al., [16] studied the cataract in atomic bomb 
survivors (873 people) who were exposed to 
ionizing radiation in their ages of under 13 
years (with estimation doses of 2Gy to eye 
lens) and the opacity of the eye lens investi-
gated at age 55; they reported that most of the 
people had cortical, subcapsular and central. 
In 2006, Nakashima et al., [12] re-analyzed 
cataract threshold dose in atomic bomb sur-
vivors. The number of 873 persons aged less 
than 13 years were considered, and examina-
tions were conducted at age 55. Subcapsular 
and cortical cataracts were common types.
There is different latent period for the induc-
tion of cataract from 6 months to more than 
50 years in literature. It has been reported that 
cataract latent period becomes shorter with 
increasing dose. According to our results, the 
opacity can occur within 3 months after the 
completion of radiation therapy. The results 
of several studies suggest that a radiation-in-
duced cataract is a definite late effect [9].
Based on this study, dose- response of the 
curve for radiation-induced cataracts is a up-
ward concave liner-quadratic curve with any 
threshold dose. Wilde et al., [17] studied the 
cataract formation in adults whose eye lenses 
were irradiated with radium-226. Many years 
in their study, 20 children (age 2-13 months) 
Figure 3: Maximum opacity of the eye lens in 6 months after radiation therapy
14
J Biomed Phys Eng 2021; 11(1)
Cataract Induction in Radiotherapy
with hemangioma of the eyelid and surround-
ing tissue irradiated with gamma rays of ra-
dium-226 sources were examined at the age of 
31 to 46 years by Slit-lamp. In their study, the 
eye lens with an average dose of 1-8 Gy suf-
fered from cataract, and the minimum dose to 
cause turbidity was obtained as 0.1Gy [17]. In 
a clinical study of cataract caused by acute ex-
posure, radiation dose for induction of opacity 
in eye lenses was obtained as 1.3 Gy [18]. Dig 
et al., [19] have reported the observed dose 
of 4-15 Gy for cataract formation in patients 
who received whole body radiation. ICRP No. 
60 in 1990 and 103 in 2007, published toler-
ance dose of 2 Gy in chronic exposure and 4 
Gy in acute radiation for cataract formation 
[11, 10]. In another study, absorbed doses of 3 
Gy with threshold dose of about 0.8 Gy have 
been reported for atomic bomb survivors two 
years after exposure to ionizing radiation [20]. 
The International Committee of Radiobiologi-
cal Protection at No. 118 (2011) has reported 
the lowest dose of about 0.5 Gy as a threshold 
dose for inducing cataract in lens [10]. Based 
on the review conducted in 2009 by Ainsbury 
et al., [21] it has been reported that the thresh-
old dose has a decreasing trend, and cataract is 
a definite effect which can be more accurately 
definable by a linear model without threshold. 
In another study, the prevalence of cataract 12 
to14 years after exposure among Chernobyl 
workers has been studied; and as a result, a 
liner-quadratic curve with upward concavity 
was proposed for radiation-induced cataract 
[22]. It is recommended that all patients with 
head and neck cancers, even when the eyes are 
located outside the radiation field, should be 
protected using eye shields.
Conclusion
The opacity can appear within 3 months af-
ter radiation therapy of head and neck cancers. 
Radiation-induced cataract is a definite effect, 
its dose-response curve is liner-quadratic with 
no threshold dose. Radiation-induced cata-
racts ordinarily include subcapsule, cortical 
and central.
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